Lillian J. Eichner

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer”.

HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer

(2024)10.52843/cassyni.qpdvq2

N/A

0.258DataRank · unranked

4 citations

Lillian J. Eichner

HDAC3 is critical in tumor development and therapeutic resistance in Kras -mutant non–small cell lung cancer

Science Advances(2023)10.1126/sciadv.add3243

N/A

0DataRank · unranked

73 citations

Stephanie D. Curtis, Sonja N. Brun, Caroline K. McGuire, Irena Gushterova, Joshua T. Baumgart +5 more

Targeting LKB1/STK11-mutant cancer: distinct metabolism, microenvironment, and therapeutic resistance

Trends in Pharmacological Sciences(2025)10.1016/j.tips.2025.06.008

N/A

0DataRank · unranked

8 citations

Evan Couser, Lillian J. Eichner, Allegra C. Minor